Articles |
From the Division of Cardiology (W.D.G., Y.L., E.M.), Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Md, and the Department of Pharmacology (R.M.), Medical College of Ohio, Toledo.
Correspondence to Eduardo Marban, MD, PhD, Room 844, Ross Building, 720 Rutland Ave, Baltimore, MD 21205. E-mail marban@welchlink.welch.jhu.edu.
| Abstract |
|---|
|
|
|---|
Key Words: force-[Ca2+] relation contractile proteins calpain I myocardial ischemia/reperfusion
| Introduction |
|---|
|
|
|---|
In the present study, we investigated the relative roles of soluble cytosolic factors versus structural alterations in the decreased Ca2+ responsiveness of stunned myocardium. We used thin trabeculae from control and stunned hearts and determined the force-[Ca2+] relation in the intact condition. We then quantified the Ca2+ responsiveness of the myofilaments after skinning in the same muscles, under conditions that equalized the soluble factors bathing the myofilaments. Our results show that alterations in the myofilaments themselves are entirely responsible for the observed decrease in maximal Ca2+-activated force and for most, if not all, of the decrease in Ca2+ sensitivity. As an initial test of the hypothesis that Ca2+-activated proteases produce the myofilament alterations, we examined the direct effect of calpain I, a Ca2+-activated neutral protease widely distributed in many tissues including the myocardium,8 on skinned cardiac muscle. Both maximal Ca2+-activated force and Ca2+ sensitivity were decreased by calpain I, and the effects were prevented by calpastatin (a specific calpain inhibitor9 ). Thus, Ca2+-dependent proteolysis mimics the changes in contractile protein function that have been documented in stunned myocardium.
| Materials and Methods |
|---|
|
|
|---|
15 mL/min) with
Krebs-Henseleit (K-H) solution equilibrated with 95%
O2/5% CO2. The K-H solution was
composed of (mmol/L) NaCl 120, NaHCO3 20, KCl 5,
MgCl2 1.2, glucose 10, and CaCl2 1.0, pH 7.35
to 7.40. Except as indicated below, the hearts were paced at 275 bpm
via electrodes placed over the insertion of the aorta and the right
ventricle. Isovolumic left ventricular pressure was
measured with a custom-made balloon (TSC) filled with water and
connected to a pressure transducer (Gould P23Db, Statham). The volume
of the balloon was adjusted to a diastolic pressure of
10 mm Hg, after which the balloon volume was kept constant. The
heart was placed in a water-jacketed container. An implantable
temperature probe (model 3441, Physitemp) was placed inside the right
ventricle, and the temperature was kept at 37°C. After 10 to 15
minutes, during which pressure development was allowed to stabilize,
the hearts were subjected to 20 minutes of no-flow global
ischemia at 37°C. Pacing was stopped after 3 minutes of
ischemia and restarted after 3 minutes of reperfusion. The
hearts were removed from the perfusion apparatus after 20
minutes of reperfusion and subsequently perfused with
high-K+ (20 mmol/L) K-H solution in a dissection dish at
room temperature (20°C to 22°C). Control hearts were perfused
continuously and paced at 37°C for 60 minutes and then placed in the
dissection dish.
Rat Trabeculae
Trabeculae from these two groups of hearts
(stunned
and control) were quickly dissected from the right ventricle and
mounted between a force transducer and a micromanipulator according to
the methods described previously.11 12 The dimensions
of
the unstretched trabeculae measured under a microscope
(Nikon 212219; magnification, x40) were as follows (mm): control
group, 1.92±0.20 long, 0.13±0.04 wide, and 0.09±0.03
thick (n=12);
stunned group, 2.03±0.22 long, 0.13±0.05 wide, and
0.10±0.04 thick
(n=13). The cross-sectional areas of the trabeculae
were as follows (mm2): control, 0.011±0.011; stunned,
0.013±0.009 (P=.6). The trabeculae were
superfused with K-H solution (except for 0.5 mmol/L of
CaCl2) at a rate of
10 mL/min and stimulated at 0.5 Hz.
All isolated muscle experiments were performed at room temperature
(20°C to 22°C).
Force Measurements
Force was
measured by a custom-made force transducer from a
silicon strain gauge (AEM 801, SensoNor)11 12 and was
expressed in millinewtons per square millimeter of cross-sectional
area.
Sarcomere Length Measurements
Sarcomere
length was measured by laser
diffraction11 12 and monitored routinely by the video
system. In a subset of the muscles (n=3 in each group), an electronic
measuring and computing system was used for on-line documentation
of the changes in sarcomere length during contraction. Briefly, light
diffracted by the central region of the muscle was detected by a
reticon diode linear array system (RC0100-RG512, EG&G Reticon). The
light intensity of the first order of diffraction was integrated, and
sarcomere length was determined from the median of the light intensity
distribution using a custom-made sarcomere length detection system
(Biomedical Technical Support Centre, University of Calgary, Alberta,
Canada). Diastolic sarcomere length was set at 2.20 to 2.30
µm.
Measurement of [Ca2+]i
[Ca2+]i was measured using the
free
acid form of fura 2 as described
previously.11 12 13 Fura 2
potassium salt was microinjected iontophoretically into one cell and
allowed to spread throughout the whole muscle (via gap junctions). The
tip of the microelectrode (
0.2 µm in diameter) was filled with
fura 2 salt (1 mmol/L), and the remainder of the electrode was
backfilled with 150 mmol/L KCl. After a successful impalement into a
superficial cell in the unstimulated muscle, a hyperpolarizing current
of 5 to 8 nA was passed continuously for 20 minutes. If necessary to
achieve a good signal-to-noise ratio, multiple injections (up
to three or four) were applied at different sites, with the duration of
current injection limited to <10 minutes at each site. The loading did
not affect force development. The epifluorescence of fura 2
was measured by exciting at 380 and 340 nm. The fluorescent
light was collected at 510 nm by a photomultiplier tube (R1527,
Hamamatsu). The output of the photomultiplier tube was filtered at 100
Hz, collected by an A/D converter, and stored digitally for later
analysis. [Ca2+]i was given by the
following equation (after subtraction of the
autofluorescence of the muscle):
![]() |
where R is the observed ratio of fluorescence (340/380), K'd is the apparent dissociation constant, Rmax is the ratio of 340 nm/380 nm at saturating [Ca2+], and Rmin is the ratio of 340 nm/380 nm at zero [Ca2+]. The values for K'd, Rmax, and Rmin were determined by in vivo calibrations as previously described.11 12 Rmax and Rmin were 9.55 and 0.75, respectively. The apparent K'd was 2.9 µmol/L. This value is the product of the true Kd of fura 2 for Ca2+ multiplied by the ratio of the fluorescence of the Ca2+-free to Ca2+-bound forms of fura 2 at 380 nm (Sf2/Sb2, where Sf2 is for the fluorescence of free fura at 380 nm, and Sb2 is for the fluorescence of the Ca2+-bound form of fura 2 at 380 nm; see Reference 14). The value of Sf2/Sb2 was 10.5 in our setup, and the true Kd, estimated in vivo, equaled 276 nmol/L.
Tetanization of Trabeculae
Ryanodine was used to enable
steady state activation in the
trabeculae.11 12 After 15 minutes of exposure
to ryanodine (1 µmol/L), tetanization was induced briefly (
4 to 8
seconds) by stimulating the muscles at 10 Hz. Different tetanized
forces were achieved with varied external [Ca2+]s
(0.25
to 20 mmol/L).11 12
Skinning of Trabeculae
After determination of the intact
force-[Ca2+]
relation, the trabeculae were skinned in the same bath by
15 to 25 minutes of exposure to 1% Triton X-100 in relaxing solution
containing (mmol/L) KCl 80, HEPES 25, K2EGTA 10, creatine
phosphate sodium salt (Na2CrP) 15, Na2ATP 5,
MgCl2 5.15, and leupeptin 0.5 (pH 7.2 with KOH). Varied
[Ca2+]s were achieved by mixing the relaxing
solution and
activating solution (mmol/L: Ca2+-EGTA 10, KCl 80, HEPES
25, Na2CrP 15, Na2ATP 5, MgCl2
4.75, and leupeptin 0.5, pH 7.2) in various ratios.
[Ca2+] was calculated by a computer program that was
based on the stability constants and the enthalpy values for the
various reactions from Martell and Smith,15 except values
for Mg2+-ATP and Ca2+-ATP reactions from
Pettit
and Siddiqui.16 The ionic strength of the solutions was
181 mmol/L, and the free [Mg2+] was 0.5 mmol/L. The
muscles were activated with solutions of varied
[Ca2+] while diastolic sarcomere length was
kept the same as before skinning.
Except for the omission of prior [Ca2+]i measurements, identical methods were used for skinning and activating additional unpaired stunned (n=2) and control (n=5) trabeculae. The latter were the same trabeculae used in the control phase of the calpain experiments. Calpain I was prepared from human red blood cells17 and stored in 50 mmol/L MOPS, 0.2 mmol/L EGTA, and 1 mmol/L dithiothreitol in 50% glycerol (-20°C). Leupeptin was omitted from calpain-containing solutions and from the isochronal control experiments.
Analysis of Steady State Activation
Both intact and skinned
steady state force-[Ca2+]
relations were fit with a function of the following form ("Hill
equation"):
![]() |
where Fmax is the maximal Ca2+-activated force, Ca50 is the [Ca2+] required for 50% of maximal activation, and n is the Hill coefficient.11 12 The data were also analyzed with a linearized Hill plot (log-log plot):
![]() |
where Pr is a fraction of Fmax, pCa is -log[Ca2+], and k is pCa50. In previous work in skinned muscle,18 19 the linearized Hill plot often yields two straight lines with different slopes or Hill coefficients, n1 and n2, above and below pCa50.
Statistics
Paired Student's t test, one-way
ANOVA, or
multivariate ANOVA was used for statistical
analysis of the data.20 21 A value of
P<.05 was considered to indicate significant differences
between groups. Unless otherwise indicated, pooled data are expressed
as mean±SD.
| Results |
|---|
|
|
|---|
|
Trabeculae from
both control and stunned hearts were
dissected quickly and mounted in the experimental chamber on the stage
of an inverted microscope. After mounting, each trabecula
was carefully inspected for any visible damage. Trabeculae
from stunned hearts looked entirely normal; there were no contracture
bands, and the sarcomeres were well aligned. In a previous
study,10 we found that Fmax was reduced and
that Ca50 was increased (ie, Ca2+ sensitivity
was reduced) in intact stunned trabeculae. In the
present study, we investigated what factors are responsible for the
decrease of Ca2+ responsiveness in stunned
myocardium. We first compared the values of
Fmax before and after skinning in control and stunned
trabeculae. Fig 1A
shows paired
recordings of maximal force before and after skinning of a
control muscle. Two traces of tetani are superimposed (left); the fact
that two different saturating levels of
[Ca2+]i result in the same level of force
demonstrates that Fmax was indeed achieved in the intact
muscle. The right side of Fig 1A
shows the force of the same
trabecula after skinning during activation by high (27
µmol/L) [Ca2+]. The Fmax values under
both
situations are virtually identical: 96 mN/mm2 (intact) and
98 mN/mm2 (skinned). Fig 1B
shows analogous results
from a
representative stunned trabecula. The
Fmax values are distinctly lower than in the control
muscle, both before and after skinning. Nevertheless, Fmax
remained unchanged after skinning in the stunned condition (intact, 73
mN/mm2; skinned, 69 mN/mm2) compared with the
control condition.
|
Fig 2
summarizes the paired data for
Fmax in both control and stunned trabeculae.
Fmax values of the stunned trabeculae were
significantly decreased compared with control trabeculae
(control, 114±30 mN/mm2 [intact] and 115±29
mN/mm2 [skinned]; stunned, 64±21 mN/mm2
[intact] and 71±22 mN/mm2 [skinned])
(P<.001). In both the control and stunned groups, however,
Fmax values were not different before and after skinning.
Since skinning equalizes the soluble cytosolic factors, these data
indicate that the decrease of Fmax in stunned
myocardium reflects intrinsic alterations of the
myofilaments.
|
Trabeculae contracting isometrically are known to undergo
some internal shortening due to the presence of a series elastance
(attributable to connective tissue and damaged ends).22 If
present, major differences in the extent of internal shortening
could theoretically accentuate the differences between control and
stunned myocardium. The results in Fig 3
show that this is not the case. The changes of sarcomere length during
both twitches and steady state contractions are roughly equivalent in
representative control trabeculae (Fig 3A
, left) and stunned
trabeculae (Fig 3A
,
right). Fig 3B
shows the mean data for sarcomere length in both
control
and stunned trabeculae. In control trabeculae,
the diastolic sarcomere length was 2.29±0.01 µm,
end-systolic sarcomere length was 1.97±0.11 µm, and the
degree of shortening was 0.33±0.11 µm. The values in stunned
trabeculae were virtually identical (diastolic,
2.27±0.03 µm; end-systolic, 1.98±0.08 µm; and
shortening, 0.30±0.07 µm).
|
The steady state results in Figs
1
and 2
focus on one fundamental
parameter of myofilament Ca2+ activation, the
maximal force. Two other parameters characterize the
Ca2+ sensitivity of the contractile proteins:
Ca50 and the steepness of the
force-[Ca2+]
relation (the Hill coefficient n). Previous studies have demonstrated
either a decrease in Ca2+ sensitivity of the
myofilaments2 10 or no
changes.3 7 We
determined whether the Ca2+ sensitivity is decreased in
intact stunned myocardium and, if so, whether the changes
are due to alterations of the myofilaments or to soluble cytosolic
factors. The latter merits particular attention, especially given that
some of these factors (eg, Mg2+) have been shown to be
elevated in stunned myocardium23 24 and are
known to affect Ca2+ sensitivity of the myofilaments
without affecting maximal force.11 25 In order to
measure
Ca50 reliably, a complete force-[Ca2+]
relation has to be obtained before and after skinning. Complete paired
force-[Ca2+] relations were obtained from six
muscles in
each group. Fig 4
shows normalized
force-[Ca2+] relations of the control (Fig
4A
) and
stunned (Fig 4B
) experiments. Each muscle in each group has its
own
symbol, open in the intact preparation and filled after skinning. The
force-[Ca2+] relation is shifted to the right after
skinning, as previously reported.11 Paired t
tests revealed significant differences in Ca50 between the
intact and skinned muscles in both groups (P=.001). Fig
4C
summarizes the Ca50 values of both the intact and the
skinned muscles, including results from several additional experiments
in which the force-[Ca2+] relation was determined
only
after skinning (see "Materials and Methods"); intact data are
depicted as open bars; skinned data, as filled bars. The
Ca50 values were significantly different in the respective
control and stunned muscles (intact, 0.60±0.09 µmol/L versus
0.85±0.09 µmol/L, n=6, P=.001; skinned,
1.13±0.23
µmol/L, n=11 versus 1.39±0.21 µmol/L, n=8,
P=.025). The
absolute values of the differences in Ca50 in control
versus stunned myocardium were comparable before and after
skinning (250 nmol/L [intact] versus 260 nmol/L
[skinned]). Thus,
both of the distinctive changes in myofilament function (the decrease
in Fmax and the increase in Ca50) are
comparable in skinned muscle and in intact muscle.
|
In contrast to
Fmax and Ca50, the
Hill coefficients, derived from the best fits to the Hill equation,
were no different in control versus stunned trabeculae
(P=.5). Because this parameter quantifies the
steepness of the force-[Ca2+] relation and is
crucial in
shaping the overall myofilament responsiveness, we performed linearized
Hill plot analysis to check these results. Fig 4D
shows
log-log plots of control (open circles) and stunned (solid circles)
force-[Ca2+] relations in the intact muscles. The
averages of the best fits to these linearized data are again
statistically indistinguishable (control, 4.99±1.22; stunned,
4.16±1.33; P=.2). Thus, the Hill coefficient is not
changed
in stunned myocardium. Interestingly, these intact muscle
data do not require two different Hill coefficients to obtain adequate
fits above or below pCa50, unlike published studies
in skinned muscle.18 19 This feature will be
considered
again below, when the skinned muscle results are analyzed in
detail.
Fig 5
, left, summarizes the results of the
intact muscle
experiments, whereas Fig 5
, right, shows the pooled results
after
skinning. The data were first normalized to their respective maximal
values and then scaled according to the absolute values for maximal
Ca2+-activated force in the control and stunned
conditions. Multivariate ANOVA revealed significant
differences between the force-[Ca2+] relations of
intact
control and stunned muscles (P=.01). The difference was
attributable solely to differences in Fmax and
Ca50, and not the Hill coefficient. The
force-[Ca2+] relations between skinned control and
stunned muscles were also significantly different (P=.007),
and once again, the differences were due to Fmax as well as
Ca50. Possible changes in the Hill coefficient in skinned
muscle are explored in depth in the log-log analysis of Fig 9C
and in the corresponding text.
|
|
These results implicate the contractile proteins themselves as the locus for the decreased myofilament Ca2+ responsiveness of stunned heart muscle. Since it has been established that cytosolic factors must play a relatively minor role, it is logical to wonder whether Ca2+-activated proteolysis is responsible for the modification of the contractile proteins in reperfused myocardium. We tested this idea by quantification of the force-[Ca2+] relations in skinned muscles before and after direct exposure to calpain I, a Ca2+-activated neutral protease that is plentiful in the myocardium.8
Effect of Calpain I on the Force-[Ca2+]
Relation in
Skinned Trabeculae
Fig 6
shows the changes in the
force-[Ca2+] relation before and after 20 minutes of
exposure to calpain I (18 µg/mL). The top panel shows the
experimental protocol in these experiments. After skinning, the muscles
were bathed in relaxing solution, and sarcomere length was set to 2.2
µm. Different levels of force were elicited by rapidly exposing the
muscle to activating solutions. After the control
force-[Ca2+] relation was obtained, the muscle was
activated with 10.8 µmol/L [Ca2+]; during this
activation, calpain I was applied for 20 minutes. The muscle was then
bathed again in relaxing solution, and another
force-[Ca2+] relation was measured. Sarcomere length
was
kept identical to that before exposure to calpain I. The bottom panel
shows the force-[Ca2+] relation before and after
exposure
to calpain I in this particular trabecula. Maximal force
decreased after calpain I treatment, and Ca50 doubled.
|
Fig
7
shows pooled force-[Ca2+] relations
before and after exposure to calpain I in four different muscles.
Before exposure to calpain I, Ca50 was 0.94±0.11 µmol/L.
Exposure to calpain I resulted in an increase of Ca50 to
1.36±0.21 µmol/L (P=.006 versus before exposure).
Maximal
Ca2+-activated force was also decreased from
94.3±8.3 to 56±8.5 mN/mm2 (P=.01,
paired
t test). Thus, exposure to calpain I and high
[Ca2+] decreased the Ca2+
responsiveness of
the myofilaments.
|
Effect of Calpain I on Myofilaments in the Presence of
Calpastatin
To determine whether the results shown in Fig
7
represent
a specific effect of calpain I, we performed another series of
experiments in which calpastatin was present when the muscles were
treated with calpain I. Calpastatin is a specific
endogenous calpain inhibitor.9 In
this series of experiments, calpastatin (from bovine heart, 24
µg/mL), purified as described previously,26 was added to
the activating solution containing 10.8 µmol/L
[Ca2+].
The trabeculae were then exposed to this solution, and
after force had reached a steady level, calpain I (18 µg/mL) was
added to the bath. After 20 minutes, the activating solution was
rapidly replaced by relaxing solution free of calpain and calpastatin.
Fig 8
shows the average force-[Ca2+]
relations before and after calpain I exposure in the presence of
calpastatin in three muscles. In spite of the presence of calpain I,
Ca50 did not change (1.02±0.42 versus 1.12±0.34
µmol/L,
P=.2) when calpastatin was also present. The small
decrease in Fmax (
15%) was comparable to that observed
in four parallel experiments in which the
force-[Ca2+]
relation was compared before and after 20 minutes of exposure to 10.8
µmol/L Ca2+ without calpain I or calpastatin (data not
shown). Thus, calpastatin prevented the decreases in Ca2+
responsiveness caused specifically by exposure to calpain I.
|
Effects of Stunning on the Myofilaments Compared With Effects of
Calpain I
If Ca2+-activated proteolysis produces
stunning, the phenotype of calpain-treated muscles could
reasonably be expected to mimic that of the stunned
myocardium. Fig 9
compares stunned muscles
(Fig 9A
and 9C
) with calpain-treated muscles
(Fig 9B
and 9D
) with
regard to the changes in Fmax and Ca2+
sensitivity. In both stunned (Fig 9A
) and calpain-treated (Fig
9B
)
myocardium, Fmax is reduced by
40%. To
optimize the resolution of changes in Ca2+ sensitivity,
fractional force was displayed as a function of activator
[Ca2+] in log-log plots (Fig 9C
and
9D
). The slopes
of the relations yield the Hill coefficients; the x
intercept corresponds to pCa50. Both stunning (Fig
9C
) and
calpain (Fig 9D
) produce rightward shifts in pCa50.
The
changes in the Hill coefficient are also uncannily similar in the two
groups. In agreement with previous studies in skinned
muscle18 19 (but not in intact muscle; compare with
Fig 4D
), the relations in the control condition are bent and
require two
linear segments, one above and the other below the abscissa, for an
adequate fit. Two Hill coefficients result: that above the abscissa
(n1) is shallower than that below (n2). It is
notable that this characteristic bent shape is lost in both stunned
(Fig 9C
) and calpain-treated (Fig 9D
) muscles;
along with the
overall shift to the right, the log-log force-[Ca2+]
relation becomes quite linear. As a result, n1 increases
slightly, while n2 decreases significantly (Table
2
). The mechanistic implications of these changes are
discussed below; what merits particular emphasis here is the striking
similarity between the effects of stunning and those of calpain, not
just the overall changes but also their quantitative details.
|
| Discussion |
|---|
|
|
|---|
The Role of Alterations of the Myofilaments in the Decreased
Ca2+ Responsiveness of Stunned
Myocardium
Our results showing a fixed decrease in Fmax in
stunned myocardium are inconsistent with
studies that showed no changes in Fmax (compared with
control values) of skinned cardiac preparations.6 7
The
inconsistency may be due to the different protocols
used to produce stunning: one used low-flow regional
ischemia in porcine hearts; the other used 40 minutes of total
global ischemia in rat hearts. In addition, it is not clear
whether physiological levels of Fmax
were actually achieved in those studies, especially without parallel
comparison to Fmax under intact conditions. This concern is
heightened by the fact that the absolute values of Fmax of
both control and stunned preparations reported in these studies were
twofold to threefold smaller than the values we obtained in this and
previous studies.11 12
The observed changes in
cross-bridge cooperativity, as gauged by
Hill coefficients, are complex. Two effects merit particular mention.
First, log-log analysis reveals that the Hill coefficient,
which is known to be altered by skinning itself, changes from a single
quantity in intact muscles to two coefficients, n1 and
n2, after skinning. Second, the effects of stunning
are manifested differently before and after skinning. Although we found
that the Hill coefficient was not changed in intact muscles, the
linearized Hill plots of the skinned muscles revealed that the usual
bent shape in control muscles was replaced by a single line in both
stunned and calpain-treated muscles (Fig 9
). This type of
change
seems unique to the stunned and calpain-treated muscles, since such
changes were not seen with the desensitizing effects of
Pi,27 pH,28 ionic
strength,29 protein kinase A,30 and
length-dependent activation.31 When linearized, the
data from these studies are parallel to lower pCa50 values.
The mechanism for the convergence of the two phases of Hill plots into
a single line is not clear at present.
In our experiments, we did not
control sarcomere length during
activations, and changes in sarcomere length can affect myofilament
sensitivity. Kentish et al32 showed that the effect of
sarcomere length on the force-pCa relation was dramatic when
corrected for sarcomere shortening. However, compared with the
force-pCa relation obtained from a muscle without correction (at a
resting sarcomere length of 2.10 µm), there was a significant
reduction only in the slope of the force-pCa relation, not in
pCa50. Given the fact that our experiments were performed
at 2.20 to 2.30 µm, the effect of uncontrolled changes in sarcomere
length on pCa50 should be even smaller. Sarcomere length
does have a significant effect on the slope of the force-pCa
relation. Therefore, our values for Hill coefficients may be
underestimated. Nevertheless, we found that changes in sarcomere length
were identical in both control and stunned muscles, not only during
maximal activations but also in submaximal activations (Fig 3
).
Whatever the effects of uncontrolled changes in sarcomere length may
have been, the control and stunned muscles would have been subject to
similar errors.
Ca2+-Activated Proteases and the Stunned
Myocardium
Ca2+-activated proteases are widely
distributed in myocytes.8 Muscle-derived calpains have
been well characterized with regard to their physical and chemical
properties as well as their substrate specificity in numerous in vitro
studies. Their role in muscle physiology, however, remains largely
unknown. Previous studies involving only skinned smooth muscle fibers
have reported that calpain I decreased the
Ca2+-activated isometric force.33 The
present study provides the first direct evidence of the effects of
calpain I on the Ca2+ responsiveness of striated
muscle.
Several factors merit consideration in evaluating the
physiological relevance of our calpain I study. The
Km of calpain I for Ca2+ has
been shown to be 1 to 20 µmol/L in vitro.34 The
[Ca2+] required to activate calpains may be lower
in intact cells because of the presence of membrane phospholipids and
autolysis of calpains.35 Thus, activation of calpain I,
which constitutes
20% of total calpain in rat
myocardium, may require much lower [Ca2+] in
intact cells than in skinned cells. Myocardial stunning is always
preceded by short-lived elevation of
[Ca2+]i, which occurs during
ischemia and early reperfusion,36 37 38
and the
magnitude of the increase of [Ca2+]i
exceeds
1 to 3 µmol/L. Despite being underestimated because of
Ca2+ buffering, this value nevertheless falls within the
range of [Ca2+] required for activation of calpain I
in
vitro.8 34 Calpains cause only limited proteolysis
(ie,
they yield large protein fragments, not individual amino
acids).39 Thus, it is not surprising that possible changes
caused by calpains in stunned myocardium may not be
visualized using conventional histological methods. For
all these reasons, calpain I is a
physiologically relevant candidate for
intracellular myofilament proteolysis after ischemia and
reperfusion.
The substrate specificity of calpain I on cardiac myofibrillar proteins is not well understood at present. Most of the information concerning myofilament substrate specificity of calpain derives from studies using calpain II.39 The physiological significance of these findings is unclear, given the fact that calpain II needs millimolar [Ca2+] to be activated. A number of cardiac contractile proteins including troponins T and C, tropomyosin, and myosin have been shown to be susceptible to calpain in previous studies40 41 in which calpain II was used. Because of the similarity in the molecular structure of the protease domain of the calpains,42 it might be expected that calpain I has a similar substrate specificity. Our own preliminary studies43 44 point to troponin I as a potential target for proteolysis in the stunned myocardium. Further investigation will be required to ascertain which myofilament proteins are degraded by calpain I and how they compare with those in the stunned heart and to determine the extent of the correlation between the occurrence of such degradation and the stunned phenotype.
To date, direct evidence that calpain I is activated in stunned myocardium is lacking. Recently, Yoshida et al45 have provided new evidence that the activity of calpain I was increased after ischemia/reperfusion in rat hearts. Although the duration of ischemia they used was longer than that used in the present study, a later study46 from the same group showed that proteolysis of calspectin, a cytoskeletal protein and a specific substrate of calpain I, occurred after periods of ischemia as brief as 10 minutes, followed by 30 minutes of reperfusion. These studies suggest that calpain I may well be activated after brief ischemia followed by reperfusion.
Limitations of the Study and Future Directions
The changes in
the Ca2+ responsiveness of the
myofilaments after calpain I exposure mimic quite faithfully those that
we have found in skinned muscles from stunned hearts. Fig 9
reproduces
the data of Figs 4B
and 5
in linearized Hill
plots in order to
facilitate direct comparison. Decreases in Fmax are seen in
both stunned and calpain-treated muscles (Fig 9A
and
9B
,
respectively). Similarly, Ca50 was increased in both
stunned and calpain-treated muscles, as shown explicitly by the
linearized Hill plots (Fig 9C
and 9D
,
respectively). In addition, the
shapes of the plots changed in an identical manner in the stunned and
calpain-treated muscles. However, these similarities do not
conclusively establish the role of calpains in the pathogenesis of
myocardial stunning. The findings reported in the present study
support (but do not prove) the "proteolysis" hypothesis for
myocardial stunning. The similarities between the effects of stunning
and those of direct exposure of the myofilaments to calpain I do not
prove a causal role for calpain I in stunning. Several important
questions remain to be answered. The myofibrillar substrates of calpain
I need to be identified and matched with the putative myofibrillar
alterations in stunned myocardium. Activation of calpains
needs to be demonstrated in the process of stunning. More important,
studies designed to alleviate stunning by preventing proteolysis are
necessary to pave the way for clinical application of the proteolysis
hypothesis. At least two such strategies have already proved successful
in isolated perfused hearts.47 48
Myocardial stunning usually resolves within days, a time course consistent with protein degradation and resynthesis.49 50 Thus, the notion that Ca2+-activated proteolysis occurs during reperfusion provides a specific rationale for the characteristically slow recovery of function in the stunned myocardium.
| Acknowledgments |
|---|
Received August 9, 1995; accepted December 12, 1995.
| References |
|---|
|
|
|---|
2.
Kusuoka H, Koretsune Y, Chacko VP, Weisfeldt ML,
Marban E. Excitation-contraction coupling in
postischemic myocardium: does failure of
activator Ca2+ transients underlie
"stunning"? Circ Res. 1990;66:1268-1276.
3.
Carrozza JP Jr, Bentivegna LA, Williams CP, Kuntz RE,
Grossman W, Morgan JP. Decreased myofilament responsiveness in
myocardial stunning follows transient calcium overload during
ischemia and reperfusion. Circ
Res. 1992;71:1334-1340.
4. Kusuoka H, Porterfield JK, Weisman HF, Weisfeldt ML, Marban E. Pathophysiology and pathogenesis of stunned myocardium: depressed Ca2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest. 1987;79:950-961.
5. Kusuoka H, Marban E. Cellular mechanisms of myocardial stunning. Annu Rev Physiol. 1992;54:243-256. [Medline] [Order article via Infotrieve]
6.
Hofmann PA, Miller WP, Moss RL. Altered calcium
sensitivity of isometric tension in myocyte-sized preparations of
porcine postischemic stunned myocardium.
Circ Res. 1993;72:50-56.
7. Dietrich DLL, van Leeuwen GR, Stienen GJM, Elzinga G. Stunning does not change the relation between calcium and force in skinned rat trabeculae. J Mol Cell Cardiol. 1993;25:541-549. [Medline] [Order article via Infotrieve]
8. Mellgren RL, Murachi T. Intracellular Calcium-Dependent Proteolysis. Boca Raton, Fla: CRC Press Inc; 1990.
9. Mellgren RL, Carr TC. The protein inhibitor of calcium-dependent proteases: purification from bovine heart and possible mechanism of regulation. Arch Biochem Biophys. 1983;225:779-786. [Medline] [Order article via Infotrieve]
10.
Gao WD, Atar D, Backx PH, Marban E. Relationship
between intracellular calcium and contractile force in stunned
myocardium: direct evidence for decreased myofilament
Ca2+ responsiveness and altered diastolic
function in intact ventricular muscle.
Circ Res. 1995;76:1036-1048.
11.
Gao WD, Backx PH, Azan-Backx M, Marban E.
Myofilament Ca2+ sensitivity in intact versus skinned rat
ventricular muscle. Circ Res. 1994;74:408-415.
12.
Backx PH, Gao WD, Azan-Backx MD, Marban E. The
relationship between contractile force and intracellular
[Ca2+] in intact rat cardiac
trabeculae. J Gen Physiol. 1995;105:1-19.
13. Backx PH, ter Keurs HEDJ. Fluorescent properties of rat cardiac trabecular microinjected with fura-2 salt. Am J Physiol. 1993;72:H463-H469.
14.
Grynkiewicz G, Poenie M, Tsien RY. A new
generation of Ca2+ indicators with greatly improved
fluorescent properties. J Biol
Chem. 1985;260:3440-3450.
15. Martell AE, Smith RM. Critical Stability Constants, I-IV. New York, NY: Plenum Publishing Corp; 1974.
16. Pettit L, Siddiqui KF. The proton and metal complexes of adenyl-5'-yl imidodiphosphate. Biochem J. 1976;159:169-171. [Medline] [Order article via Infotrieve]
17.
Mellgren RL. Proteolysis of nuclear proteins by
µ-calpain and m-calpain. J Biol
Chem.. 1991;266:13920-13924.
18.
Sweitzer NK, Moss RL. The effect of altered
temperature on Ca2+-sensitive force in
permeabilized myocardium and skeletal
muscle. J Gen Physiol. 1990;96:1221-1245.
19.
McDonald KS, Field LJ, Parmacek MS, Soonpaa M, Leiden
JM, Moss RL. Length dependence of Ca2+ sensitivity
of tension in mouse cardiac myocytes expressing skeletal troponin
C. J Physiol (Lond). 1995;483:131-139.
20. Snedecor GW, Cochran WG. Statistical Methods. 8th ed. Ames, Iowa: Iowa State University Press; 1989.
21. Winer BJ. Statistical Principles in Experimental Design. 2nd ed. New York, NY: McGraw-Hill Publishing Co; 1982.
22.
ter Keurs HEDJ, Rijnsburger WH, van Heuningen R,
Nagelsmit MJ. Tension development and sarcomere length in rat
cardiac trabeculae: evidence of length-dependent
activation. Circ Res. 1980;46:703-714.
23. Kirkels JH, van Echteld CJA, Ruigrok TJC. Intracellular magnesium during myocardial ischemia and reperfusion: possible consequences for postischemic recovery. J Mol Cell Cardiol. 1989;21:1209-1218. [Medline] [Order article via Infotrieve]
24. Murphy E, Steenbergen C, Levy LA, Raju B, London RE. Cytosolic free magnesium levels in ischemic rat heart. J Biol Chem. 1989;264;5622-5627.
25.
Fabiato A, Fabiato F. Effects of magnesium on
contractile activation of skinned cardiac cells. J
Physiol (Lond). 1975;249:497-517.
26. Mellgren RL, Nettey MS, Mericle MT, Renno W, Lane RD. An improved purification procedure for calpastatin, the inhibitor protein specific for the intracellular calcium-dependent proteinases, calpains. Prep Biochem. 1988;18:183-197. [Medline] [Order article via Infotrieve]
27.
Kentish JC. The effects of inorganic phosphate
and creatine phosphate on force production in skinned muscles
from rat ventricle. J Physiol (Lond). 1986;370:585-604.
28.
Orchard CH, Kentish JC. Effects of changes of pH
on the contractile function of cardiac muscle. Am J
Physiol. 1990;258:C967-C981.
29.
Kentish JC. The inhibitory effects
of monovalent ions on force development in detergent-skinned
ventricular muscle from guinea-pig.
J Physiol (Lond). 1984;352:353-374.
30.
Zhang R, Zhao J, Mandveno A, Potter JD. Cardiac
troponin I phosphorylation increases the rate of
cardiac muscle relaxation. Circ Res. 1995;76:1028-1035.
31.
McDonald KS, Moss RL. Osmotic compression of
single cardiac myocytes eliminates the reduction in Ca2+
sensitivity of tension at short sarcomere length.
Circ Res. 1995;77:199-205.
32.
Kentish JC, ter Keurs HEDJ, Ricciardi L, Bucx JJJ,
Noble MIM. Comparison between the sarcomere length-force
relations of intact and skinned trabeculae from rat right
ventricle: influence of calcium concentrations on these
relations. Circ Res. 1986;58:755-768.
33. Haeberle JR, Coolican SA, Evan A, Hathaway DR. The effect of a calcium dependent protease on the ultrastructure and contractile mechanics of skinned uterine smooth muscle. J Muscle Res Cell Motil. 1985;6:347-363. [Medline] [Order article via Infotrieve]
34. Croall DE, Demartino GN. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev. 1991;75:813-847.
35. Suzuki K, Imajoh S, Emori Y, Kawasaki H, Minami Y, Ohno S. Calcium-activated neutral protease and its endogenous inhibitor. FEBS Lett. 1987;220:271-277. [Medline] [Order article via Infotrieve]
36.
Marban E, Kitakaze M, Koretsune Y, Yue DT, Chacko VP,
Pike MM. Quantification of [Ca2+]i of
perfused hearts: critical evaluation of the 5F-BAPTA and nuclear
magnetic resonance method as applied to the study of ischemia
and reperfusion. Circ Res. 1990;66:1255-1267.
37.
Steenbergen C, Murphy E, Levy L, London RE.
Elevation in cytosolic free calcium concentration early in myocardial
ischemia in perfused rat heart. Circ
Res. 1987;60:700-707.
38.
Kihara Y, Grossman W, Morgan JP. Direct
measurement of changes in intracellular calcium transients during
hypoxia, ischemia, and reperfusion of the intact
mammalian heart. Circ Res. 1989;65:1029-1044.
39. Takahashi K. Calpain substrate specificity. In: Mellgren RL, Murachi T, eds. Intracellular Calcium-Dependent Proteolysis. Boca Raton, Fla: CRC Press Inc; 1990:56-74.
40.
Hara K, Ichihara S, Suzuki K, Imahori K.
Purification and characterization of a calcium-activated
neutral protease from monkey cardiac muscle. J
Biochem (Tokyo). 1983;93:1435-1445.
41. Toyo-oka T, Masaki T. Calcium-activated neutral protease from bovine ventricular muscle: isolation and some of its properties. J Mol Cell Cardiol. 1979;11:769-786. [Medline] [Order article via Infotrieve]
42. Suzuki K. The structure of calpains and the calpain gene. In: Mellgren RL, Murachi T, eds. Intracellular Calcium-Dependent Proteolysis. Boca Raton, Fla: CRC Press Inc; 1990:26-35.
43. Atar D, Gao WD, Backx PH, Murphy AM, Marban E. Immunoblot analysis of stunned myocardium reveals structural alterations of the myofilaments predicted by modeling of cross-bridge kinetics. Circulation. 1994;90(suppl I):I-646. Abstract.
44. Gao WD, Atar D, Liu Y, Murphy AM, Marban E. Degradation of troponin I in ischemic/reperfused myocardium: molecular basis of myocardial stunning? Biophys J. 1995;68:A112. Abstract.
45. Yoshida K, Sorimachi Y, Fujiwara M, Hironaka K. Calpain is implicated in rat myocardial injury after ischemia or reperfusion. Jpn Circ J. 1995;59:40-48. [Medline] [Order article via Infotrieve]
46.
Yoshida K, Inui M, Harada K, Saido TC, Sorimachi Y,
Ishihara T, Kawashima S, Sobue K. Reperfusion of rat heart after
brief ischemia induces proteolysis of calspectin (nonerythroid
spectrin or fodrin) by calpain. Circ Res. 1995;77:603-610.
47. Matsumura Y, Kusuoka H, Inoue M, Hori M, Kamada T. Protective effect of the protease inhibitor leupeptin against myocardial stunning. J Cardiovasc Pharmacol. 1993;22:135-142. [Medline] [Order article via Infotrieve]
48. Walker AA, Harris KD, Digerness SB, Urthaler F. MDL 28170, a calpain inhibitor, attenuates myocardial stunning. J Mol Cell Cardiol. 1995;27:A8. Abstract.
49.
McKee EE, Cheung JY, Rannels DE, Morgan HE.
Measurement of the rate of protein synthesis and compartmentation of
heart phenylalanine. J Biol Chem. 1978;253:1030-1040.
50.
Martin AF. Turnover of cardiac troponin
subunits: kinetic evidence for a precursor pool of troponin-I.
J Biol Chem. 1981;256:964-968.
This article has been cited by other articles:
![]() |
X.-Y. Lu, L. Chen, X.-L. Cai, and H.-T. Yang Overexpression of heat shock protein 27 protects against ischaemia/reperfusion-induced cardiac dysfunction via stabilization of troponin I and T Cardiovasc Res, August 1, 2008; 79(3): 500 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shan, R. B. Marchase, and J. C. Chatham Overexpression of TRPC3 increases apoptosis but not necrosis in response to ischemia-reperfusion in adult mouse cardiomyocytes Am J Physiol Cell Physiol, March 1, 2008; 294(3): C833 - C841. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, R. B. Marchase, and J. C. Chatham Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1391 - H1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Wu, F. M. Bengel, and S. S. Gambhir Cardiovascular Molecular Imaging Radiology, August 1, 2007; 244(2): 337 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dai, Y. Tian, C. G. Tocchetti, T. Katori, A. M. Murphy, D. A. Kass, N. Paolocci, and W. D. Gao Nitroxyl increases force development in rat cardiac muscle J. Physiol., May 1, 2007; 580(3): 951 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Varian, S. Raman, and P. M. L. Janssen Measurement of myofilament calcium sensitivity at physiological temperature in intact cardiac trabeculae Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2092 - H2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Gao, T. Dai, and D. Nyhan Increased cross-bridge cycling rate in stunned myocardium Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H886 - H893. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Arteaga, C. M. Warren, S. Milutinovic, A. F. Martin, and R. J. Solaro Specific enhancement of sarcomeric response to Ca2+ protects murine myocardium against ischemia-reperfusion dysfunction Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2183 - H2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Woldbaek, J. B. Sande, T. A. Stromme, P. K. Lunde, S. Djurovic, T. Lyberg, G. Christensen, and T. Tonnessen Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H708 - H714. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sumida, H. Otani, S. Kyoi, T. Okada, H. Fujiwara, Y. Nakao, M. Kido, and H. Imamura Temporary blockade of contractility during reperfusion elicits a cardioprotective effect of the p38 MAP kinase inhibitor SB-203580 Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2726 - H2734. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R Moopanar and D. G Allen Reactive oxygen species reduce myofibrillar Ca2+ sensitivity in fatiguing mouse skeletal muscle at 37{degrees}C J. Physiol., April 1, 2005; 564(1): 189 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Lalu, E. Pasini, C. J. Schulze, M. Ferrari-Vivaldi, G. Ferrari-Vivaldi, T. Bachetti, and R. Schulz Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart Eur. Heart J., January 1, 2005; 26(1): 27 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Louch, G. R. Ferrier, and S. E. Howlett Attentuation of Cardiac Stunning by Losartan in a Cellular Model of Ischemia and Reperfusion Is Accompanied by Increased Sarcoplasmic Reticulum Ca2+ Stores and Prevention of Cytosolic Ca2+ Elevation J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 238 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Asemu, N. S. Dhalla, and P. S. Tappia Inhibition of PLC improves postischemic recovery in isolated rat heart Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2598 - H2605. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Stull, M. K. Leppo, L. Szweda, W. D. Gao, and E. Marban Chronic Treatment With Allopurinol Boosts Survival and Cardiac Contractility in Murine Postischemic Cardiomyopathy Circ. Res., November 12, 2004; 95(10): 1005 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Spindler, K. Meyer, H. Stromer, A. Leupold, E. Boehm, H. Wagner, and S. Neubauer Creatine kinase-deficient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1039 - H1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Lim, C. Zuppinger, X. Guo, G. M. Kuster, M. Helmes, H. M. Eppenberger, T. M. Suter, R. Liao, and D. B. Sawyer Anthracyclines Induce Calpain-dependent Titin Proteolysis and Necrosis in Cardiomyocytes J. Biol. Chem., February 27, 2004; 279(9): 8290 - 8299. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Krombach, M. Saeed, C. B. Higgins, V. Novikov, and M. F. Wendland Contrast-enhanced MR Delineation of Stunned Myocardium with Administration of MnCl2 in Rats Radiology, January 1, 2004; 230(1): 183 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Marston and C. S. Redwood Modulation of Thin Filament Activation by Breakdown or Isoform Switching of Thin Filament Proteins: Physiological and Pathological Implications Circ. Res., December 12, 2003; 93(12): 1170 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Foster, T. Noguchi, P. VanBuren, A. M. Murphy, and J. E. Van Eyk C-Terminal Truncation of Cardiac Troponin I Causes Divergent Effects on ATPase and Force: Implications for the Pathophysiology of Myocardial Stunning Circ. Res., November 14, 2003; 93(10): 917 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Huang, S. F. Vatner, A. P. Peppas, G. Yang, and R. K. Kudej Cardiac Nerves Affect Myocardial Stunning Through Reactive Oxygen and Nitric Oxide Mechanisms Circ. Res., October 31, 2003; 93(9): 866 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J Ashton, K. Holmgren, J. Peart, A. R Lankford, G Paul Matherne, S. Grimmond, and J. P Headrick Effects of A1 adenosine receptor overexpression on normoxic and post-ischemic gene expression Cardiovasc Res, March 1, 2003; 57(3): 715 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Kudej, L. T. White, A. B. Kudej, S. F. Vatner, and E. D. Lewandowski Brief Increase in Carbohydrate Oxidation After Reperfusion Reverses Myocardial Stunning in Conscious Pigs Circulation, November 26, 2002; 106(22): 2836 - 2841. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van der Laarse Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure Cardiovasc Res, October 1, 2002; 56(1): 8 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Nicolosi, G. West, J. G. Markley, B. Logan, and G. N. Olinger Gadolinium attenuates regional stunning in the canine heart in vivo J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 57 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verma, P. W.M. Fedak, R. D. Weisel, J. Butany, V. Rao, A. Maitland, R.-K. Li, B. Dhillon, and T. M. Yau Fundamentals of Reperfusion Injury for the Clinical Cardiologist Circulation, May 21, 2002; 105(20): 2332 - 2336. [Full Text] [PDF] |
||||
![]() |
O. Zeitz, A. E. Maass, P. Van Nguyen, G. Hensmann, H. Kogler, K. Moller, G. Hasenfuss, and P. M.L. Janssen Hydroxyl Radical-Induced Acute Diastolic Dysfunction Is Due to Calcium Overload via Reverse-Mode Na+-Ca2+ Exchange Circ. Res., May 17, 2002; 90(9): 988 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ruetten, C. Badorff, C. Ihling, A. M. Zeiher, and S. Dimmeler Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects J. Am. Coll. Cardiol., December 1, 2001; 38(7): 2063 - 2070. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mazhari, J. H. Omens, R. S. Pavelec, J. W. Covell, and A. D. McCulloch Transmural Distribution of Three-Dimensional Systolic Strains in Stunned Myocardium Circulation, July 17, 2001; 104(3): 336 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hendrikx, F. Rega, L. Jamaer, T. Valkenborgh, H. Gutermann, and U. Mees Na+/H+-exchange inhibition and aprotinin administration: promising tools for myocardial protection during minimally invasive CABG Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 633 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sun, D. Chartier, N. Leblanc, and S. Nattel Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes Cardiovasc Res, March 1, 2001; 49(4): 751 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. G. Wang, W. J. Benedict, J. Huser, A. M. Samarel, L. A. Blatter, and S. L. Lipsius Brief rapid pacing depresses contractile function via Ca2+/PKC-dependent signaling in cat ventricular myocytes Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H90 - H98. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Pyle, T. D. Smith, and P. A. Hofmann Cardioprotection with kappa -opioid receptor stimulation is associated with a slowing of cross-bridge cycling Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1941 - H1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Van de Velde, M. DeWolff, H.A. Leather, and P. F. Wouters Effects of lipids on the functional and metabolic recovery from global myocardial stunning in isolated rabbit hearts Cardiovasc Res, October 1, 2000; 48(1): 129 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Rappaport Ischemia-reperfusion associated myocardial contractile dysfunction may depend on Ca2+-activated cytoskeleton protein degradation Cardiovasc Res, March 1, 2000; 45(4): 810 - 812. [Full Text] [PDF] |
||||
![]() |
Z. Papp, J. van der Velden, and G.J.M Stienen Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes of rat heart Cardiovasc Res, March 1, 2000; 45(4): 981 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Depre and H. Taegtmeyer Metabolic aspects of programmed cell survival and cell death in the heart Cardiovasc Res, February 1, 2000; 45(3): 538 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Murphy, H. Kögler, D. Georgakopoulos, J. L. McDonough, D. A. Kass, J. E. Van Eyk, and E. Marbán Transgenic Mouse Model of Stunned Myocardium Science, January 21, 2000; 287(5452): 488 - 491. [Abstract] [Full Text] |
||||
![]() |
G. J. Gross, J. R. Kersten, and D. C. Warltier Mechanisms of postischemic contractile dysfunction Ann. Thorac. Surg., November 1, 1999; 68(5): 1898 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schad, W. Heimisch, G. P. Eising, and N. Mendler Effect of dopamine and atrial pacing on stunned myocardium Eur. J. Cardiothorac. Surg., June 1, 1999; 13(6): 710 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Gwathmey, C. S. Kim, R. J. Hajjar, F. Khan, T. G. DiSalvo, A. Matsumori, and M. R. Bristow Cellular and molecular remodeling in a heart failure model treated with the beta -blocker carteolol Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1678 - H1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bolli and E. Marban Molecular and Cellular Mechanisms of Myocardial Stunning Physiol Rev, April 1, 1999; 79(2): 609 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Kondo, C. S. Apstein, F. R. Eberli, D. L. Tillotson, and T. M. Suter Increased calcium loading and inotropy without greater cell death in hypoxic rat cardiomyocytes Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2272 - H2282. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kloner, R. Bolli, E. Marban, L. Reinlib, and E. Braunwald Medical and Cellular Implications of Stunning, Hibernation, and Preconditioning : An NHLBI Workshop Circulation, May 19, 1998; 97(18): 1848 - 1867. [Full Text] [PDF] |
||||
![]() |
H.M. Piper, D. Garcna-Dorado, and M. Ovize A fresh look at reperfusion injury Cardiovasc Res, May 1, 1998; 38(2): 291 - 300. [Full Text] [PDF] |
||||
![]() |
H. Luss, P. Bokniek, G. Heusch, F. U. Muller, J. Neumann, W. Schmitz, and R. Schulz Expression of calcium regulatory proteins in short-term hibernation and stunning in the in situ porcine heart Cardiovasc Res, March 1, 1998; 37(3): 606 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Gao, N. G. Perez, and E. Marban Calcium cycling and contractile activation in intact mouse cardiac muscle J. Physiol., February 15, 1998; 507(1): 175 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsumura, E. Saeki, M. Inoue, M. Hori, T. Kamada, and H. Kusuoka Inhomogeneous Disappearance of Myofilament-Related Cytoskeletal Proteins in Stunned Myocardium of Guinea Pig Circ. Res., September 1, 1996; 79(3): 447 - 454. [Abstract] [Full Text] |
||||
![]() |
M. Chen, H. He, S. Zhan, S. Krajewski, J. C. Reed, and R. A. Gottlieb Bid Is Cleaved by Calpain to an Active Fragment in Vitro and during Myocardial Ischemia/Reperfusion J. Biol. Chem., August 10, 2001; 276(33): 30724 - 30728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Kim, R. K. Kudej, A. Yatani, Y.-K. Kim, G. Takagi, R. Honda, D. A. Colantonio, J. E. Van Eyk, D. E. Vatner, R. L. Rasmusson, et al. A Novel Mechanism for Myocardial Stunning Involving Impaired Ca2+ Handling Circ. Res., October 26, 2001; 89(9): 831 - 837. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |